Reports for AA PHARMA INC
Company Name
AA PHARMA INC
Shortage reports
Actual shortage:
21 (5%)
Anticipated shortage:
0 (0%)
Avoided shortage:
6 (1%)
Resolved:
433 (94%)
460
Discontinuation Reports
To be discontinued:
9 (14%)
Discontinued:
52 (83%)
Reversed:
2 (3%)
63
30 (6%)
20 (67%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PHENYTOIN SODIUM | 100MG | CAPSULE | Resolved | 2020-06-04 | 2020-07-13 | 116554 |
| APO-PHENYTOIN SODIUM | 100MG | CAPSULE | Resolved | 2020-09-09 | 2020-09-21 | 123960 |
| APO-PINAVERIUM | 50MG | TABLET | Resolved | 2019-07-03 | 2019-08-31 | 88339 |
| APO-PINAVERIUM | 50MG | TABLET | Resolved | 2020-09-22 | 2020-10-05 | 124792 |
| APO-PINAVERIUM | 100MG | TABLET | Resolved | 2019-08-07 | 2019-08-31 | 91100 |
| APO-PINAVERIUM | 100MG | TABLET | Resolved | 2020-09-02 | 2020-10-05 | 123571 |
| APO-PINAVERIUM | 100MG | TABLET | Resolved | 2021-01-29 | 2021-02-09 | 132735 |
| APO-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-10-29 | 2021-11-19 | 148545 |
| APO-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-03-18 | 2022-04-06 | 156999 |
| APO-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-10-14 | 2023-01-06 | 171833 |
| APO-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-12-02 | 2022-12-23 | 176948 |
| APO-ROSIGLITAZONE | 2MG | TABLET | Resolved | 2017-07-26 | 2017-10-16 | 17325 |
| APO-ROSIGLITAZONE | 4MG | TABLET | Resolved | 2017-08-24 | 2017-10-16 | 20214 |
| APO-SELEGILINE | 5MG | TABLET | Resolved | 2017-07-26 | 2018-03-27 | 17328 |
| APO-SELEGILINE | 5MG | TABLET | Resolved | 2019-06-19 | 2019-07-19 | 87064 |
| APO-THEO LA | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-04-24 | 2021-10-14 | 82343 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2018-05-02 | 2018-07-12 | 47972 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2019-03-13 | 2019-04-05 | 78555 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2023-02-23 | 2023-03-02 | 185462 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2023-08-12 | 2023-09-29 | 201713 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PHENYTOIN SODIUM | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-12-28 | 60687 |
| AVENTYL | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65435 |
| CHLORAX | 2.5MG 5MG | CAPSULE | Discontinued | 2022-01-20 | 2022-01-21 | 153244 |
| CHLORDIAZEPOXIDE | 10MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231340 |
| CHLORDIAZEPOXIDE | 5MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231343 |
| CHLORDIAZEPOXIDE | 25MG | CAPSULE | To be discontinued | 2024-06-26 | 2024-06-26 | 231348 |
| DIFLUNISAL | 250MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108364 |
| DIFLUNISAL | 500MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108367 |
| DOXEPIN | 50MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65463 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247839 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247836 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247833 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247830 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247827 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247824 |
| ELAVIL | 75MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247842 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2022-04-01 | 2022-04-02 | 157808 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4584 |
| ERYTHRO-ES | Discontinued | 2018-12-07 | 2018-12-08 | 68904 | ||
| ERYTHRO-ES | 600MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121825 |